{"id":4654,"date":"2018-10-03T19:53:00","date_gmt":"2018-10-03T17:53:00","guid":{"rendered":"https:\/\/patientenstimme-sma.de\/?page_id=4654"},"modified":"2026-03-16T21:04:51","modified_gmt":"2026-03-16T20:04:51","slug":"neues-zu-risdiplam-vorlaeufige-beweise-fuer-klinischen-nutzen-bei-typ-1-2-und-3","status":"publish","type":"post","link":"https:\/\/smartunity.space\/stories\/thema\/neues-zu-risdiplam-vorlaeufige-beweise-fuer-klinischen-nutzen-bei-typ-1-2-und-3\/","title":{"rendered":"Neues zu Risdiplam &#8211; vorl\u00e4ufige Beweise f\u00fcr klinischen Nutzen bei Typ 1, 2 und 3"},"content":{"rendered":"\n<p class=\"tw-text-wide\">Zitat:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-style-default is-layout-flow wp-block-quote-is-layout-flow\">\n<p><span style=\"font-size: 1rem\">&#8220;Risdiplam zeigt vorl\u00e4ufige Beweise f\u00fcr klinischen Nutzen bei Patienten mit spinaler Muskelatrophie Typ 1, 2 und 3&#8221;<\/span><\/p>\n\n\n\n<p><strong>&#8220;<\/strong>South Plainfield, New Jersey, 3. Oktober 2018 \/ PRNewswire \/ &#8211; PTC Therapeutics, Inc.(NASDAQ: PTCT) gab heute klinische Zwischenergebnisse aus Teil 1 der offenen Studien von FIREFISH und SUNFISH bekannt, die den Nutzen von Risdiplam (RG7916) f\u00fcr die Behandlung von spinaler Muskelatrophie Typ 1, 2 und 3 demonstrieren.<strong>&#8220;<\/strong><\/p>\n<\/blockquote>\n\n\n\n<p class=\"tw-text-wide\">Quelle:&nbsp;<a href=\"https:\/\/www.prnewswire.com\/news-releases\/risdiplam-demonstrates-preliminary-evidence-of-clinical-benefit-in-type-1-2--3-spinal-muscular-atrophy-patients-300723444.html\">https:\/\/www.prnewswire.com\/news-releases\/risdiplam-demonstrates-preliminary-evidence-of-clinical-benefit-in-type-1-2&#8211;3-spinal-muscular-atrophy-patients-300723444.html<\/a><\/p>\n\n\n\n<p class=\"tw-text-wide\"><a href=\"https:\/\/translate.google.com\/translate?sl=en&amp;tl=de&amp;js=y&amp;prev=_t&amp;hl=de&amp;ie=UTF-8&amp;u=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Frisdiplam-demonstrates-preliminary-evidence-of-clinical-benefit-in-type-1-2--3-spinal-muscular-atrophy-patients-300723444.html&amp;edit-text=&amp;act=url\" target=\"_blank\" rel=\"noopener noreferrer\">Link \u00fcber Google-Translate zur direkten \u00dcbersetzung<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zitat: &#8220;Risdiplam zeigt vorl\u00e4ufige Beweise f\u00fcr klinischen Nutzen bei Patienten mit spinaler Muskelatrophie Typ 1, 2 und 3&#8221; &#8220;South Plainfield, New Jersey, 3. Oktober 2018 \/ PRNewswire \/ &#8211; PTC Therapeutics, Inc.(NASDAQ: PTCT) gab heute klinische Zwischenergebnisse aus Teil 1 der offenen Studien von FIREFISH und SUNFISH bekannt, die den Nutzen von Risdiplam (RG7916) f\u00fcr [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"only-view","format":"standard","meta":{"activitypub_content_warning":"","activitypub_content_visibility":"local","activitypub_max_image_attachments":0,"activitypub_interaction_policy_quote":"anyone","activitypub_status":"","footnotes":""},"categories":[1],"tags":[58],"class_list":["post-4654","post","type-post","status-publish","format-standard","hentry","category-thema","tag-smanews"],"_links":{"self":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts\/4654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/comments?post=4654"}],"version-history":[{"count":2,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts\/4654\/revisions"}],"predecessor-version":[{"id":39923,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts\/4654\/revisions\/39923"}],"wp:attachment":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/media?parent=4654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/categories?post=4654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/tags?post=4654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}